Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial

Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial

Abstract Background Glioblastoma is a rapidly proliferating tumor. Patients bear an inferior prognosis with a median survival time of 14-16 months. Proliferation and repopulation are a major resistance promoting factor for conventionally fractionated radiotherapy. Tumor-Treating-Fields (TTFields) ar...

Full description

Bibliographic Details
Main Authors: N. Guberina, C. Pöttgen, S. Kebir, L. Lazaridis, C. Scharmberg, W. Lübcke, M. Niessen, M. Guberina, B. Scheffler, V. Jendrossek, R. Jabbarli, D. Pierscianek, U. Sure, T. Schmidt, C. Oster, P. Hau, A. L. Grosu, M. Stuschke, M. Glas, Y. Nour, L. Lüdemann
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Radiation Oncology
Subjects:
Dosimetry
Non-coplanar IMRT
Glioblastoma
TTFields
Online Access:http://link.springer.com/article/10.1186/s13014-020-01521-7

Internet

http://link.springer.com/article/10.1186/s13014-020-01521-7

Similar Items